Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation

Overview of attention for article published in Frontiers in Molecular Biosciences, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Centro Grossi Paoletti, 11 Oct 2022

È nota l’efficacia degli inibitori della proproteina convertasi subtilisina/kexin tipo 9 (PCSK9), alirocumab ed evolocumab, nel…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.